| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.06 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.06 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.099 | 0.07 |